World's Best Scientists 2026 revealed!
Joost C. M. Meijers

Joost C. M. Meijers

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
28050
World Ranking
2232
National Ranking
49

Medicine

D-Index
93
Citations
30942
World Ranking
10913
National Ranking
431

Overview

Joost C. M. Meijers is affiliated with the University of Amsterdam in the Netherlands and has contributed extensively to the field of Medicine, with a particular focus on Hematology, Genetics, Cardiology and Cardiovascular Medicine, Internal Medicine, and Rheumatology. Their research portfolio includes over a hundred publications, with notable emphasis on blood coagulation and thrombosis mechanisms.

Their main research topics cover a range of areas related to hematology and cardiovascular medicine, including:

  • Blood Coagulation and Thrombosis Mechanisms
  • Platelet Disorders and Treatments
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Venous Thromboembolism Diagnosis and Management
  • Blood groups and transfusion
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Trauma, Hemostasis, Coagulopathy, Resuscitation

Meijers has published frequently in specialized journals, including:

  • Journal of Thrombosis and Haemostasis (15 publications)
  • Research and Practice in Thrombosis and Haemostasis (10 publications)
  • Thrombosis and Haemostasis (5 publications)
  • Seminars in Thrombosis and Hemostasis (3 publications)
  • Blood (3 publications)

Some recent papers authored or co-authored by Meijers highlight contributions to understanding hereditary angioedema, cardiovascular biomarkers, lupus anticoagulant mechanisms, cerebral venous thrombosis, and platelet activation in antiphospholipid syndrome. Notable examples of these papers are:

  • "Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema," 2020, New England Journal of Medicine
  • "MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability," 2020, Open Heart
  • "Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action," 2021, Journal of Thrombosis and Haemostasis
  • "Prediction of cerebral venous thrombosis with a new clinical score and D-dimer levels," 2020, Neurology
  • "Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?", 2021, Journal of Thrombosis and Haemostasis

Meijers regularly collaborates with a set of frequent co-authors, including:

  • Kamran Bakhtiari
  • Awital Bar Barroeta
  • J. Arnoud Marquart
  • Philip G. de Groot
  • Rolf T. Urbanus

Best Publications

  • Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

    Elise S. Eerenberg;Pieter Willem Kamphuisen;Meertien K. Sijpkens;Joost C. Meijers

  • High levels of coagulation factor XI as a risk factor for venous thrombosis.

    Joost C.M. Meijers;Winnie L.H. Tekelenburg;Bonno N. Bouma;Rogier M. Bertina

  • Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo

    Max Nieuwdorp;Timon W. van Haeften;Mirella C.L.G. Gouverneur;Hans L. Mooij

  • Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation.

    Kamran Bakhtiari;Joost C M Meijers;Evert de Jonge;Marcel Levi

  • Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

    Mirjam E. Meltzer;Mirjam E. Meltzer;Ton Lisman;Ton Lisman;Philip G. de Groot;Joost C.M. Meijers

  • KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium

    Rob J. Dekker;Reinier A. Boon;Mariska G. Rondaij;Astrid Kragt

  • Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis

    P. A. K. Von Dem Borne;J. C. M. Meijers;B. N. Bouma

  • Hyperglycemia: a prothrombotic factor?

    B. A. Lemkes;J. Hermanides;J. H. Devries;F. Holleman

  • Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

    Nick R. Bijsterveld;Arno H. Moons;S. Matthijs Boekholdt;Benien E. van Aken

  • Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo

    Marieke A.D. van Zoelen;Huan Yang;Sandrine Florquin;Joost C.M. Meijers

  • Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.

    Michiel E. Stegenga;Saskia N. van der Crabben;Regje M. E. Blümer;Marcel Levi

  • Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis

    Ton Lisman;Frank W.G. Leebeek;Laurent O. Mosnier;Bonno N. Bouma

  • Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

    Jan Rosing;Saskia Middeldorp;Joyce Curvers;M Christella L GDlig

  • Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.

    J. A. Koedam;J. C. M. Meijers;J. J. Sixma;B. N. Bouma

  • Review: Viral infections and mechanisms of thrombosis and bleeding.

    M. Goeijenbier;M. van Wissen;C. van de Weg;E. Jong

  • Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

    Eduard J. van Beers;Marianne C.L. Schaap;René J. Berckmans;Rienk Nieuwland

  • Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

    P. A. K. Von Dem Borne;L. Bajzar;J. C. M. Meijers;M. E. Nesheim

  • Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

    Catharina Jacoba Maria Doggen;Frits R. Rosendaal;Joost C.M. Meijers

  • Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation

    L. O. Mosnier;P. A. K. Von Dem Borne;J. C. M. Meijers;B. N. Bouma

  • KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium

    Reinier A. Boon;Rob J. Dekker;Mariska G. Rondaij;Oscar L. Volger

Frequent Co-Authors

Marcel Levi
Marcel Levi University of Amsterdam
Tom van der Poll
Tom van der Poll University of Amsterdam
Bonno N. Bouma
Bonno N. Bouma Scripps Research Institute
Ton Lisman
Ton Lisman University Medical Center Groningen
Joris J. T. H. Roelofs
Joris J. T. H. Roelofs University of Amsterdam
Harry R. Büller
Harry R. Büller University of Amsterdam
Cornelis van 't Veer
Cornelis van 't Veer University of Amsterdam
Saskia Middeldorp
Saskia Middeldorp Radboud University Medical Center
Rienk Nieuwland
Rienk Nieuwland University of Amsterdam
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA can open doors to broad career paths. With the rise of digital learning, many students now consider online degrees that blend life sciences with healthcare or management. One popular option is an affordable online mba in healthcare management, which equips graduates with both scientific knowledge and leadership skills for roles in hospitals, research organizations, and biotechnology firms.

Another alternative is a career in healthcare administration or medical data, such as billing and coding. Those interested in this direction will want to understand the distinction between certifications like cpc vs ccs, as these affect your career options and earning potential. If you're curious about income levels, see the current medical coding salary ranges, which can vary based on education, certification, and experience.

The healthcare data field offers good job stability and flexible work arrangements. For a balanced overview of your prospects, review the job outlook for medical billing and coding—helpful for anyone exploring alternative career pathways after a sciences degree.

Best Scientists Citing Joost C. M. Meijers

Trending Scientists

Recently Published Articles